Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures – SHINE

Brief summary (registry, in English)

To compare the efficacy of BHV-7000 to placebo as adjunctive therapy for subjects with IGE with GTC as measured by the time to the second day with a GTC seizure during the double-blind phase.

What you commit to

• Study type: Interventional · Phase 2/3
• Participants enrolled: 122
• 60 sites in 11 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (60)

Sites in registry order. Save your city in your profile to sort them by distance.